ロード中...
Evolved bacterial resistance against fluoropyrimidines can lower chemotherapy impact in the Caenorhabditis elegans host
Metabolism of host-targeted drugs by the microbiome can substantially impact host treatment success. However, since many host-targeted drugs inadvertently hamper microbiome growth, repeated drug administration can lead to microbiome evolutionary adaptation. We tested if evolved bacterial resistance...
保存先:
| 出版年: | eLife |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
eLife Sciences Publications, Ltd
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7725501/ https://ncbi.nlm.nih.gov/pubmed/33252330 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7554/eLife.59831 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|